Endovascular embolization — a minimally invasive surgery that cuts off blood flow from a specific group of blood vessels in…
Articles by Joana Carvalho, PhD
LIQ861, Liquidia Technologies’ proprietary inhaled dry powder formulation of the vasodilator treprostinil,…
When used alone or in combination with other therapies, Opsumit (macitentan) can lower the mortality risk in patients with…
The Pulmonary Hypertension Association (PHA) is inviting the patient community to participate in its virtual fashion show,…
Janssen Korea and Johnson & Johnson Innovation have launched an initiative to help advance breakthrough innovations to improve…
Sotatercept (ACE-011) leads to clinically meaningful reductions in heart strain and improvements in functional capacity…
CAR peptide (CAR), Vascular BioSciences’ lead therapeutic peptide candidate for pulmonary hypertension (PH) and other disorders, was…
Bayer has opened its second annual Pulmonary Hypertension Accelerated Bayer (PHAB) Awards, a grant funding program…
Obesity is linked to a lower risk of mortality in patients with pulmonary hypertension (PH), particularly among those…
When given alone or in combination with other therapies, Opsumit (macitentan) leads to clinically meaningful improvements in right heart…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to CS1, Cereno Scientific’s…
The U.S. Food and Drug Administration (FDA) has accepted for review the new drug application (NDA)…